A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00743496
Recruitment Status : Completed
First Posted : August 28, 2008
Last Update Posted : August 17, 2017
Evan T.J. Dunbar Neuroblastoma Foundation
Duke University
University of Wisconsin, Madison
University Children’s Hospital Tuebingen
Children's Hospital Los Angeles
Information provided by (Responsible Party):
St. Jude Children's Research Hospital